| Name | Title | Contact Details |
|---|---|---|
Sharon Bridges |
Vice President and Deputy General Counsel | Profile |
Renee Wroth |
Chief Compliance and Privacy Officer | Profile |
Vanessa Smith |
Vice President and Chief General Counsel | Profile |
Michael Knapik |
Vice President, Government and Community Relations | Profile |
Kyle Deskus |
Assistant General Counsel | Profile |
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.
Scryptions International is a Henderson, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Landmark Health Solutions Company is a Haverhill, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Envoy Medical Corporation is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Novus Biologicals is a Littleton, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.